Mirae Asset Global Investments
BLTE

Mirae Asset Global Investments’s Belite Bio BLTE Stock Holding History

Mirae Asset Global Investments’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.4K Sell
470
-187
-28% -$28.7K ﹤0.01% 1305
2026
Q1 		$105K Buy
657
+12
+2% +$2.02K ﹤0.01% 1172
2025
Q4 		$103K Buy
+645
New +$76.4K ﹤0.01% 1250
2025
Q1 		– Sell
-357
Closed -$22.1K – 1600
2024
Q4 		$22.1K Buy
+357
New +$23.5K ﹤0.01% 1409

Other funds holding BLTE

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
HNWAG
High Net Worth Advisory Group Naples, Florida $471M AUM 22.07% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Mirae Asset Global Investments's BLTE Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Belite Bio (BLTE) stake by 28% in Q2 2026, selling an estimated $28.7K and leaving 470 shares worth $72.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1305.

Mirae Asset Global Investments first reported a position in BLTE in Q4 2024 and has held it in 4 quarters since. The position peaked at $105K in Q1 2026. 12 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Mirae Asset Global Investments held 470 shares of Belite Bio worth $72.4K as of Q2 2026.
  • Mirae Asset Global Investments sold 187 Belite Bio shares in Q2 2026, an estimated $28.7K.
  • Belite Bio made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1305 holding.
  • Mirae Asset Global Investments first reported a position in Belite Bio in Q4 2024 and has held it in 4 quarters since.
  • Mirae Asset Global Investments's Belite Bio position peaked at $105K in Q1 2026.
  • 12 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.